345 related articles for article (PubMed ID: 21526116)
1. Functional characterization of the plasmacytoma variant translocation 1 gene (PVT1) in diabetic nephropathy.
Alvarez ML; DiStefano JK
PLoS One; 2011 Apr; 6(4):e18671. PubMed ID: 21526116
[TBL] [Abstract][Full Text] [Related]
2. Role of microRNA 1207-5P and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathy.
Alvarez ML; Khosroheidari M; Eddy E; Kiefer J
PLoS One; 2013; 8(10):e77468. PubMed ID: 24204837
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of plasmacytoma variant translocation 1 (PVT1) inhibits high glucose-induced proliferation and renal fibrosis in HRMCs by regulating miR-23b-3p/early growth response factor 1 (EGR1).
Yu D; Yang X; Zhu Y; Xu F; Zhang H; Qiu Z
Endocr J; 2021 May; 68(5):519-529. PubMed ID: 33408314
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA circRNA_15698 aggravates the extracellular matrix of diabetic nephropathy mesangial cells via miR-185/TGF-β1.
Hu W; Han Q; Zhao L; Wang L
J Cell Physiol; 2019 Feb; 234(2):1469-1476. PubMed ID: 30054916
[TBL] [Abstract][Full Text] [Related]
6. Plasmacytoma Variant Translocation 1 (PVT1) Gene as a Potential Novel Target for the Treatment of Diabetic Nephropathy.
Mok H; Al-Jumaily A; Lu J
Biomedicines; 2022 Oct; 10(11):. PubMed ID: 36359234
[No Abstract] [Full Text] [Related]
7. Repression of let-7 by transforming growth factor-β1-induced Lin28 upregulates collagen expression in glomerular mesangial cells under diabetic conditions.
Park JT; Kato M; Lanting L; Castro N; Nam BY; Wang M; Kang SW; Natarajan R
Am J Physiol Renal Physiol; 2014 Dec; 307(12):F1390-403. PubMed ID: 25354942
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1.
Yu X; Li C; Li X; Cai L
Toxicol Sci; 2007 Apr; 96(2):346-56. PubMed ID: 17264099
[TBL] [Abstract][Full Text] [Related]
9. A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathy.
Huang Y; Border WA; Yu L; Zhang J; Lawrence DA; Noble NA
J Am Soc Nephrol; 2008 Feb; 19(2):329-38. PubMed ID: 18216319
[TBL] [Abstract][Full Text] [Related]
10. Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammation.
Zhou G; Cheung AK; Liu X; Huang Y
Clin Sci (Lond); 2014 May; 126(10):707-20. PubMed ID: 24195695
[TBL] [Abstract][Full Text] [Related]
11. Transcription Factor Egr1 is Involved in High Glucose-Induced Proliferation and Fibrosis in Rat Glomerular Mesangial Cells.
Wang D; Guan MP; Zheng ZJ; Li WQ; Lyv FP; Pang RY; Xue YM
Cell Physiol Biochem; 2015; 36(6):2093-107. PubMed ID: 26279418
[TBL] [Abstract][Full Text] [Related]
12. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.
Wahab NA; Schaefer L; Weston BS; Yiannikouris O; Wright A; Babelova A; Schaefer R; Mason RM
Diabetologia; 2005 Dec; 48(12):2650-60. PubMed ID: 16270194
[TBL] [Abstract][Full Text] [Related]
13. Metformin inhibits extracellular matrix accumulation, inflammation and proliferation of mesangial cells in diabetic nephropathy by regulating H19/miR-143-3p/TGF-β1 axis.
Xu J; Xiang P; Liu L; Sun J; Ye S
J Pharm Pharmacol; 2020 Aug; 72(8):1101-1109. PubMed ID: 32391614
[TBL] [Abstract][Full Text] [Related]
14. Relaxin Inhibits High Glucose-Induced Matrix Accumulation in Human Mesangial Cells by Interfering with TGF-β1 Production and Mesangial Cells Phenotypic Transition.
Xie X; Xia W; Fei X; Xu Q; Yang X; Qiu D; Wang M
Biol Pharm Bull; 2015; 38(10):1464-9. PubMed ID: 26424011
[TBL] [Abstract][Full Text] [Related]
15. Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes.
Seo JY; Park J; Yu MR; Kim YS; Ha H; Lee HB
Am J Nephrol; 2009; 30(6):481-90. PubMed ID: 19786738
[TBL] [Abstract][Full Text] [Related]
16. Aldosterone and TGF-beta1 synergistically increase PAI-1 and decrease matrix degradation in rat renal mesangial and fibroblast cells.
Huang W; Xu C; Kahng KW; Noble NA; Border WA; Huang Y
Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1287-95. PubMed ID: 18367662
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the FoxO1 Ameliorates Mesangial Cell Dysfunction in Male Diabetic Rats.
Qin G; Zhou Y; Guo F; Ren L; Wu L; Zhang Y; Ma X; Wang Q
Mol Endocrinol; 2015 Jul; 29(7):1080-91. PubMed ID: 26029993
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-beta1-induced kidney disease.
Krag S; Danielsen CC; Carmeliet P; Nyengaard J; Wogensen L
Kidney Int; 2005 Dec; 68(6):2651-66. PubMed ID: 16316341
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b.
Wang B; Jha JC; Hagiwara S; McClelland AD; Jandeleit-Dahm K; Thomas MC; Cooper ME; Kantharidis P
Kidney Int; 2014 Feb; 85(2):352-61. PubMed ID: 24088962
[TBL] [Abstract][Full Text] [Related]
20. Glibenclamide prevents increased extracellular matrix formation induced by high glucose concentration in mesangial cells.
Giannico G; Cortes P; Baccora MH; Hassett C; Taube DW; Yee J
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F57-65. PubMed ID: 16896180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
